The landscape of treatment for bronchiectasis could change significantly with the approval of brensocatib, offering a more ...

GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious diseases that mainly impact lower-income countries. The initiative will focus on vaccines and ...

The non-profit International Society for Infectious Diseases (ISID) has published a set of six priorities focusing on the challenges faced by low- and middle-income countries (LMICs) ahead of its ...

Different dosages of brensocatib proved effective in treating people living with bronchiectasis when studied in the ASPEN ...

May 29, 2025 — The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even ... Machine Learning Algorithm ...

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to 64 years at high risk for severe disease, aligning with the agency ...

The CDC tweaked — but did not remove — its recommendation for COVID-19 vaccination in children, days after HHS Secretary Robert F. Kennedy Jr. said the agency would stop recommending the shots ...

Jake & Jordan break down the drama from the wild mid-week Mets vs. Red Sox series. Plus, the guys check-in on who is in the lead for the end of season awards as we near the one-third mark of the year ...

The Lancet Infectious Diseases The Lancet Microbe The Lancet Neurology The Lancet Obstetrics, ... Michael Crosby, Johann S de Bono, Ken Herrmann, Guilhem Roubaud, James Nagarajah, Mark Fleming, Brian ...